# Vitalant – FDA Inspection, Jul 24, 2019

Source: https://www.keypedia.com/records/fda_inspections/vitalant/26cc3371-aac5-4e23-8fc4-15a8ef5110b3
Source feed: FDA_Inspections

> FDA inspection 1097452 of Vitalant, July 24, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1097452
- Company Name: Vitalant
- Inspection Date: 2019-07-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 917998 - 2015-02-06](https://www.keypedia.com/records/fda_inspections/vitalant/62a706e3-8d99-4a89-b399-e7aa22ea6661)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/bryce-a-may/39683196-5fff-4608-808c-7f10df606f7b)
- [FDA Associated Person](https://www.keypedia.com/people/kip-j-hanks/839cb755-ff60-448c-9b21-b84b78b59a15)
- [Company Rep](https://www.keypedia.com/people/marc-a-jackson/3bb8df6e-ab3a-4106-9a4b-aaaa307bc051)

Company: https://www.keypedia.com/companies/vitalant/22d14b59-7237-4669-8216-ec5ca5dd7434

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
